Cardinal Health Statistics
Total Valuation
Cardinal Health has a market cap or net worth of $50.75 billion. The enterprise value is $55.90 billion.
| Market Cap | 50.75B |
| Enterprise Value | 55.90B |
Important Dates
The next estimated earnings date is Thursday, October 29, 2026, before market open.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | Oct 1, 2026 |
Share Statistics
Cardinal Health has 231.56 million shares outstanding. The number of shares has decreased by -2.07% in one year.
| Current Share Class | 231.56M |
| Shares Outstanding | 231.56M |
| Shares Change (YoY) | -2.07% |
| Shares Change (QoQ) | -0.42% |
| Owned by Insiders (%) | 0.12% |
| Owned by Institutions (%) | 90.90% |
| Float | 231.02M |
Valuation Ratios
The trailing PE ratio is 30.47 and the forward PE ratio is 17.53. Cardinal Health's PEG ratio is 1.18.
| PE Ratio | 30.47 |
| Forward PE | 17.53 |
| PS Ratio | 0.20 |
| Forward PS | 0.19 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 11.27 |
| P/OCF Ratio | 9.86 |
| PEG Ratio | 1.18 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.23, with an EV/FCF ratio of 12.41.
| EV / Earnings | 32.76 |
| EV / Sales | 0.22 |
| EV / EBITDA | 13.23 |
| EV / EBIT | 17.08 |
| EV / FCF | 12.41 |
Financial Position
The company has a current ratio of 0.88
| Current Ratio | 0.88 |
| Quick Ratio | 0.43 |
| Debt / Equity | n/a |
| Debt / EBITDA | 2.20 |
| Debt / FCF | 2.21 |
| Interest Coverage | 9.45 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 3.72% |
| Return on Invested Capital (ROIC) | 18.36% |
| Return on Capital Employed (ROCE) | 24.55% |
| Weighted Average Cost of Capital (WACC) | 6.39% |
| Revenue Per Employee | $3.98M |
| Profits Per Employee | $26,823 |
| Employee Count | 63,900 |
| Asset Turnover | 4.61 |
| Inventory Turnover | 14.33 |
Taxes
In the past 12 months, Cardinal Health has paid $469.00 million in taxes.
| Income Tax | 469.00M |
| Effective Tax Rate | 21.57% |
Stock Price Statistics
The stock price has increased by +43.32% in the last 52 weeks. The beta is 0.52, so Cardinal Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | +43.32% |
| 50-Day Moving Average | 232.56 |
| 200-Day Moving Average | 217.48 |
| Relative Strength Index (RSI) | 32.70 |
| Average Volume (20 Days) | 1,755,598 |
Short Selling Information
The latest short interest is 6.67 million, so 2.88% of the outstanding shares have been sold short.
| Short Interest | 6.67M |
| Short Previous Month | 6.39M |
| Short % of Shares Out | 2.88% |
| Short % of Float | 2.89% |
| Short Ratio (days to cover) | 4.49 |
Income Statement
In the last 12 months, Cardinal Health had revenue of $254.25 billion and earned $1.71 billion in profits. Earnings per share was $7.23.
| Revenue | 254.25B |
| Gross Profit | 9.77B |
| Operating Income | 3.29B |
| Pretax Income | 2.17B |
| Net Income | 1.71B |
| EBITDA | 4.24B |
| EBIT | 3.29B |
| Earnings Per Share (EPS) | $7.23 |
Balance Sheet
The company has $4.86 billion in cash and $10.00 billion in debt, with a net cash position of -$5.14 billion or -$22.21 per share.
| Cash & Cash Equivalents | 4.86B |
| Total Debt | 10.00B |
| Net Cash | -5.14B |
| Net Cash Per Share | -$22.21 |
| Equity (Book Value) | -2.72B |
| Book Value Per Share | -12.37 |
| Working Capital | -5.15B |
Cash Flow
In the last 12 months, operating cash flow was $5.17 billion and capital expenditures -$649.00 million, giving a free cash flow of $4.53 billion.
| Operating Cash Flow | 5.17B |
| Capital Expenditures | -649.00M |
| Depreciation & Amortization | 956.00M |
| Net Borrowing | 337.00M |
| Free Cash Flow | 4.53B |
| FCF Per Share | $19.54 |
Margins
Gross margin is 3.84%, with operating and profit margins of 1.29% and 0.67%.
| Gross Margin | 3.84% |
| Operating Margin | 1.29% |
| Pretax Margin | 0.86% |
| Profit Margin | 0.67% |
| EBITDA Margin | 1.67% |
| EBIT Margin | 1.29% |
| FCF Margin | 1.78% |
Dividends & Yields
This stock pays an annual dividend of $2.06, which amounts to a dividend yield of 0.94%.
| Dividend Per Share | $2.06 |
| Dividend Yield | 0.94% |
| Dividend Growth (YoY) | 1.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 28.54% |
| FCF Payout Ratio | 10.56% |
| Buyback Yield | 2.07% |
| Shareholder Yield | 3.00% |
| Earnings Yield | 3.36% |
| FCF Yield | 8.87% |
Analyst Forecast
The average price target for Cardinal Health is $270.94, which is 23.62% higher than the current price. The consensus rating is "Buy".
| Price Target | $270.94 |
| Price Target Difference | 23.62% |
| Analyst Consensus | Buy |
| Analyst Count | 18 |
| Revenue Growth Forecast (3Y) | 5.52% |
| EPS Growth Forecast (3Y) | 12.48% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 23, 2001. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Apr 23, 2001 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
Cardinal Health has an Altman Z-Score of 5.02 and a Piotroski F-Score of 7.
| Altman Z-Score | 5.02 |
| Piotroski F-Score | 7 |